Regional Corporate Account Director - IDN

F2G; United States; In loco; USD 140.000 - 230.000; Tempo pieno

Descrizione del lavoro

F2G is seeking a Regional Corporate Account Director to drive product growth and build partnerships through optimal formulary access and reimbursement for olorofim. The focus areas include Integrated Delivery Networks, Hospitals and Health Systems, and Regional Health Plans across the geography.

You will serve as the face of the company with IDNs, Payers and PBMs, lead payer account strategies, negotiate contracts, and collaborate with Sales, Contracting and Marketing.

Competenze

• BS required; advanced degree preferred.
• Minimum of 10 years’ experience in pharmaceutical industry.
• Minimum of 5 years direct IDN/health-system/key account-management experience.
• Demonstrated existing relationships with key access customers (IDNs, Payers, PBMs).
• Experience and knowledge of rare diseases in the market access arena.

Mansioni

• Drive product growth through optimal formulary access and reimbursement.
• Lead the payer account strategic plan at a local level and negotiate contracts.
• Develop and manage relationships with Sales, Contracting, and Marketing; interact with Medical Affairs as needed.
• Demonstrate strong communication and presentation skills with cross-functional teams.
• Travel approximately 35% to cover regional accounts.

Conoscenze

Pharma experience

Key account mgmt

Communication skills

Travel 35%

Formazione

Bachelor's degree

Advanced degree preferred

Descrizione del lavoro

Title: Regional Corporate Account Director - IDN (Multiple Roles)

Reporting to: Senior Director, Lead Field Market Access

About F2G

F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections. F2G has discovered and developed a completely new class of antifungal agents called the orotomides. The orotomides have a distinct mechanism of action, selectively targeting fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine biosynthesis pathway. This differentiates the orotomides from the currently marketed antifungal agents. Olorofim (formerly F901318) is F2G’s leading candidate from this class and has fungicidal activity against a broad range of mold infections, including a variety of rare and resistant molds that cause life-threatening infections for which current therapies have limitations or are ineffective.

F2G has completed a Phase 3 randomized clinical study to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with Invasive Fungal Disease Caused by Aspergillus Species and received positive topline data in June 2026. A previous Phase 2b open-label study of olorofim focused on rare and resistant invasive fungal infections including invasive aspergillosis (including azole-resistant strains), coccidioidomycosis and scedosporiosis (including lomentosporiosis). Olorofim has received orphan drug status from the European Medicines Agency and orphan drug status, Qualified Infectious Disease Product (QIDP) designation, and Breakthrough Therapy designation from FDA.

F2G is headquartered in the UK with subsidiaries in the US and Austria.

Our Vision

F2G’s vision is to bring to market safe, convenient, and effective novel antifungal agents to challenge a global unmet need for therapies that are active against resistant infections and also against pathogens which have historically been difficult to treat. Olorofim is the first novel anti-fungal treatment developed in the past 20 years and is the only antifungal medication ever to be awarded a Breakthrough Therapy Designation for multiple designations by the FDA. F2G believes that olorofim, and subsequent agents, will address some of the many challenges which face the treating physician and the patient with invasive fungal infections.

The Role:

The Regional Corporate Account Director’s primary responsibility is to drive product growth and business partnerships through optimal formulary access and reimbursement for olorofim and future products. The main areas of focus are Integrated Delivery Networks/Hospitals and Health Systems and Regional Health Plans. This role may involve multiple assignments including regional payers, PBMs, GPOs, Health Systems, and others. Within these customers, the candidate is expected to be the face of the organization, engaging all segments of each account from pharmacy to C‑Suite.

In engaging customers, the candidate will demonstrate expert account-based selling. Core competencies will include the abilities to: influence using clinical data, provide customer‑centric insights via health economic data and value propositions, negotiate contracts, and build meaningful relationships at all customer levels. Throughout these engagements, the candidate will demonstrate patient and customer focus, support of organizational goals, and adept ability to meet corporate financial milestones.

Additionally, as the main access representative within a given geography, the candidate is expected to provide leadership and partnership with critical counterparts such as Sales, Contracting, and Marketing. This role is critical to bringing strategic insights into the organization. As well, the candidate will lead in creation and pull‑through of local access plans.

Key Responsibilities:

• Demonstrate interpersonal skills in establishing solid working relationships with Sales, Marketing, Contracting, Medical Affairs and other key departments to ensure adoption and execution of overall strategic plan and exceeding performance targets
• Demonstrate an in‑depth understanding of the managed market landscape, customers, reimbursement and trends
• Work with payers and IDNs in the geography
• Ability to understand reimbursement and access dynamics of highly complex specialty/rare disease products and develop strategic plans to find opportunities to maximize performance and growth
• Develop and lead the payer account strategic plan at a local level
• Must be a skilled negotiator, able to develop and deliver contracts/agreements with an IDN and payer
• Operate outside the typical sales cycles and focus on revenue growthContinuously build strong relationships with established customers
• Own, drive and close the entire customer adoption cycle end‑to‑end

What You Bring to The Table:

• BS required. Advanced degree is preferred
• Minimum of 10 years’ experience in the pharmaceutical industry/life sciences
• Minimum of 5 years of direct IDN, health‑system, or key account‑management experience
• Demonstrated existing relationships with key access customers (IDN’s, Payers, PBM’s, etc)
• Experience and knowledge of rare diseases in the market access arena
• Strong experience in contracts and supply agreements, customer relations and, strategic and tactical sales
• PBM/Plan/GPO experience is preferred
• Strong technical background in Life Sciences - ability to speak fluently about biological sciences and techniques, inclusive of health economic data
• Comfortable operating within uncertain, fast‑paced and competitive environments
• Comfortable working in a small company environment
• Strong communication and presentation skills
• Able to travel for conferences, company meetings, account meetings, etc. (approximately 35%)

Additional Responsibilities and Accountabilities:

• Ability to understand reimbursement and access dynamics of highly complex specialty/rare disease products and develop strategic plans to find opportunities to maximize performance and growth
• Demonstrate an in‑depth understanding of the managed market landscape, customers, reimbursement and trends. Effectively communicate this knowledge to Sales, Marketing, Medical Affairs and other core cross functional teams
• Demonstrate interpersonal skills in establishing solid working relationships with Sales, Marketing, Contracting, Medical Affairs and other key departments to ensure adoption and execution of overall strategic plan and exceeding of performance targets
• Work with patient advocacy groups, payers, and IDNs in the geography
• Develop and lead the payer account strategic plan at a local level
• Operate outside the typical sales cycles and focus on revenue growth
• Ensure F2G exceeds its financial targets through focus on individual account GTN impact
• Continuously build strong relationships with established customers
• Own, drive and close the entire customer adoption cycle end‑to‑end